Inform Genomics Selects US Oncology Research as the Site Management Organization (SMO) for Pivotal Multicenter Study of OnPART
29 mai 2015 16h00 HE
|
Inform Genomics
Boston, MA, May 29, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to discover and develop
genomic-based, precision medicine...